How is the Theravance Biopharma Inc today?

The Theravance Biopharma Inc today is trading in the down by -2.18% at 10.77.

How has Theravance Biopharma Inc performed historically?

The Theravance Biopharma Inc is currently trading down -2.18% on an intraday basis in the past week the index rose 15.81%. The index has been up 10.80% in the past quarter and rose 19.93% in the past year. You can view this in the overview section.

What is Theravance Biopharma Inc Annual Revenue?

Theravance Biopharma Inc Annual Revenue rose 12.12%, in the last year to $64.38 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Theravance Biopharma Inc Annual Net Profit?

Theravance Biopharma Inc Annual Net Profit fell 2.22% in the last year to $56.42 M. Its sector's average net profit growth for the last fiscal year was -13.88%.

What is Theravance Biopharma Inc Price to Earning Ratio?

Theravance Biopharma Inc Price to Earning Ratio is -9.23, which is negative.

What is Theravance Biopharma Inc Stock Price?

Theravance Biopharma Inc Stock Price rose 19.93% and underperformed its sector by 8.04% in the past year.

What is Theravance Biopharma Inc Quarterly Revenue?

Theravance Biopharma Inc Quarterly Revenue rose 6.1% YoY to $15.39 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Theravance Biopharma Inc Quarterly Net profit?

Theravance Biopharma Inc Quarterly Net profit fell 16.42% YoY to $13.58 M. Its sector's average net profit growth YoY for the quarter was -239.15%.

What is Theravance Biopharma Inc Debt to Equity Ratio?

Theravance Biopharma Inc Debt to Equity Ratio of 0.28 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Theravance Biopharma Inc Return on Equity(ROE)?

Theravance Biopharma Inc Return on Equity(ROE) for the last financial year was -29.04%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Theravance Biopharma Inc Mutual Fund Holding?

Theravance Biopharma Inc Mutual Fund Holding decreased by 0.58% in the last quarter to 24.19.

What is Theravance Biopharma Inc Promoter Share Holding?

Theravance Biopharma Inc Promoter Share Holding increased by 0.03% in the most recent quarter to 5.56%.

What is Theravance Biopharma Inc Interest Coverage Ratio?

Theravance Biopharma Inc Interest Coverage Ratio is -16.52, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Theravance Biopharma Inc Institutional Holding?

Theravance Biopharma Inc Institutional Holding decreased by 1.43% in the last quarter to 88.59.

Theravance Biopharma Inc XNAS: TBPH

Theravance Biopharma Inc Live Share Price Today, Share Analysis and Chart

Name: Theravance Biopharma Inc: Is Infosys Ltd. worth buying?
Item: Theravance Biopharma Inc
Rating: 1.581652875
Author: Trendlyne DVM scores

Momentum Trap

about

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient...

10.77 -0.24 (-2.18%)

New 52W High in past week

261.3K XNAS Volume

XNAS 05 Jun, 2025 5:30 PM (EDT)

Low Financial Strength

27.8 / 100

Expensive Valuation

6.7 / 100

Technically Moderately Bullish

64.3 / 100

Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM

1Yr Price target upside is 42%

4 analysts

Theravance Biopharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Theravance Biopharma Inc Live Share Price Today, Share Analysis and Chart

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient...

New 52W High in past week

SWOT Analysis

Theravance Biopharma Inc Live Price Chart

Theravance Biopharma Inc FAQ

How is Theravance Biopharma Inc today?

Theravance Biopharma Inc today is trading in the red, and is down by -2.18% at 10.77.

How has Theravance Biopharma Inc performed historically?

Theravance Biopharma Inc is currently trading down -2.18% on an intraday basis. In the past week the stock rose 15.81%. stock has been up 10.80% in the past quarter and rose 19.93% in the past year. You can view this in the overview section.